Orthofix Medical Inc. Finance Lease, Right-of-Use Asset, after Accumulated Amortization
Orthofix Medical Inc. (OFIX) had Finance Lease, Right-of-Use Asset, after Accumulated Amortization of $9.29 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:FinanceLeaseRightOfUseAsset · last filed 2026-08-05
- 2026-06-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $9.29M.
- 2026-03-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $9.46M.
- 2025-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $14.44M.
- 2025-09-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $14.65M.
| Period end | Finance Lease, Right-of-Use Asset, after Accumulated Amortization |
|---|---|
| 2026-06-30 | $9.29M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $9.46M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $14.44M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $14.65M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $14.91M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $15.13M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $15.39M 10-K · filed 2026-02-24 |
| 2024-09-30 | $15.64M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $15.84M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $16.09M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $16.34M 10-K · filed 2025-02-25 |
| 2023-09-30 | $16.60M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $16.85M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $17.11M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $17.36M 10-K · filed 2024-03-05 |
| 2022-09-30 | $17.61M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $17.87M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $18.12M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $18.60M 10-K · filed 2023-03-06 |
| 2021-09-30 | $19.11M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $19.64M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $20.07M 10-Q · filed 2021-04-30 |
| 2020-12-31 | $20.55M 10-K · filed 2022-02-25 |
| 2020-09-30 | $21.00M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $21.40M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $21.91M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $20.21M 10-K · filed 2021-02-26 |
| 2019-09-30 | $20.45M 10-Q · filed 2019-10-28 |
| 2019-06-30 | $20.70M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $20.94M 10-Q · filed 2019-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |